Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by mollevi
Group name EquipeCG
Item Type Note
Note

Michaelson, M Dror
Oudard, Stephane
Ou, Yen-Chuan
Sengelov, Lisa
Saad, Fred
Houede, Nadine
Ostler, Peter
Stenzl, Arnulf
Daugaard, Gedske
Jones, Robert
Laestadius, Fredrik
Ullen, Anders
Bahl, Amit
Castellano, Daniel
Gschwend, Juergen
Maurina, Tristan
Chow Maneval, Edna
Wang, Shaw-Ling
Lechuga, Maria Jose
Paolini, Jolanda
Chen, Isan
eng
Clinical Trial, Phase III
Comparative Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
2013/12/11 06:00
J Clin Oncol. 2014 Jan 10;32(2):76-82. doi: 10.1200/JCO.2012.48.5268. Epub 2013 Dec 9.

Date Added 2018/07/20 - 10:05:58
Date Modified 2018/07/20 - 10:05:58
Parent item Randomized, placebo-controlled, phase III trial of sunitinib plus prednisone versus prednisone alone in progressive, metastatic, castration-resistant prostate cancer


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés